Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Daniel Betticher"'
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Breast cancer screening mammography is widespread in industrialised countries within the framework of public health program or opportunist form. Only few data exist on the comparison of effectiveness between organised and opportun
Externí odkaz:
https://doaj.org/article/ace0aaa177944698bd458f31def5d965
Autor:
Anne Gerber, André Da Silva Lopes, Natacha Szüts, Michael Simon, Viviane Ribordy‐Baudat, Andreas Ebneter, Claire Perrinjaquet, Marie‐Estelle Gaignard, Delphine Nicodet, Daniel Betticher, Grégoire Bula, Maxime Cote, Michel André Duchosal, Pierre‐André Berret, Pierre‐Yves Dietrich, Caitlin Brennan, Sandy Decosterd, Sandrina Ferreira Nobre, Solange Peters, Reto Koelliker, Françoise Ninane, Marie‐Madlen Jeitziner, Sara Colomer‐Lahiguera, Manuela Eicher
Publikováno v:
Health Science Reports, Vol 3, Iss 2, Pp n/a-n/a (2020)
Abstract Background and aims The occurrence rate of adverse events (AEs) related to care among hospitalized oncology patients in Switzerland remains unknown. The primary objective of this study was to describe, for the first time, the occurrence rate
Externí odkaz:
https://doaj.org/article/d5ae6c013a44450fbe34db168af17ccd
Autor:
Albina Nowak, Anne Angelillo-Scherrer, Daniel Betticher, Michael Dickenmann, Idris Guessous, Pascal Juillerat, Wolfgang Korte, Stefan Neuner-Jehle, Otmar Pfister, Daniel Surbek, Edouard Battegay, Johann Steurer
Publikováno v:
Swiss Medical Weekly, Vol 149, Iss 2728 (2019)
AIMS OF THE STUDY Iron deficiency (ID) and iron deficiency anaemia (IDA) are important conditions affecting a large proportion of the general population, causing the patients physical and psychosomatic symptoms, particularly fatigue, and significant
Externí odkaz:
https://doaj.org/article/666db5ba329b45e99be5cdc5ff0413c0
Autor:
Panagiotis Samaras, Mario Bargetzi, Daniel Betticher, Michel Duchosal, Dominik Heim, Urs Hess, Nicolas Ketterer, Erika Lerch, Thomas Matthes, Ulrich Mey, Thomas Pabst, Christian Taverna, Thilo Zander, Christoph Renner
Publikováno v:
Swiss Medical Weekly, Vol 145, Iss 0708 (2015)
The availability of drugs such as thalidomide, bortezomib and lenalidomide changed the landscape in myeloma treatment and has extended the median survival up to 10 years with a substantial improvement in quality of life. This development prompted a S
Externí odkaz:
https://doaj.org/article/6b48cbe11677433baae0ff2f570eb5af
Autor:
Florent Baty, Sacha Rothschild, Martin Früh, Daniel Betticher, Cornelia Dröge, Richard Cathomas, Daniel Rauch, Oliver Gautschi, Lukas Bubendorf, Susanne Crowe, Francesco Zappa, Miklos Pless, Martin Brutsche, Swiss Group for Clinical Cancer Research
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e72966 (2013)
Activating epidermal growth factor receptor (EGFR) mutations are recognized biomarkers for patients with metastatic non-small cell lung cancer (NSCLC) treated with EGFR tyrosine kinase inhibitors (TKIs). EGFR TKIs can also have activity against NSCLC
Externí odkaz:
https://doaj.org/article/df9c71b1c1b54bdabc04d593f01a7ee1
Autor:
Martin H. Brutsche, Francesco Zappa, Dirk Klingbiel, Bogdan D. Grigoriu, Daniel Betticher, Cornelia Droege, Oliver Dürr, Ina I. Macovei, Florent Baty, Anca Franzini
Supplementary Tables 1-3, Figures 1-6. Supplementary Table 1: Statistical analysis of differences between the study group and the remaining group of patients for several variables. Supplementary Table 2: Primers used for the RT-qPCR assays. Supplemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c31bd2b21ad1a4b111d6e71f4b5ef858
https://doi.org/10.1158/1078-0432.22460262
https://doi.org/10.1158/1078-0432.22460262
Autor:
Martin H. Brutsche, Francesco Zappa, Dirk Klingbiel, Bogdan D. Grigoriu, Daniel Betticher, Cornelia Droege, Oliver Dürr, Ina I. Macovei, Florent Baty, Anca Franzini
Purpose: We aimed to identify gene expression signatures associated with angiogenesis and hypoxia pathways with predictive value for treatment response to bevacizumab/erlotinib (BE) of nonsquamous advanced non–small cell lung cancer (NSCLC) patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08efad0a4bb21684f86bf406f495d712
https://doi.org/10.1158/1078-0432.c.6524439.v1
https://doi.org/10.1158/1078-0432.c.6524439.v1
Autor:
Katarzyna Furrer, Walter Weder, Eric Innocents Eboulet, Daniel Betticher, Miklos Pless, Roger Stupp, Thorsten Krueger, Jean Yannis Perentes, Ralph A. Schmid, Didier Lardinois, Markus Furrer, Martin Früh, Solange Peters, Alessandra Curioni-Fontecedro, Rolf A. Stahel, Sacha I. Rothschild, Stefanie Hayoz, Isabelle Opitz
OBJECTIVE Surgical treatment of locally advanced non-small cell lung cancer including single or multilevel N2 remains a matter of debate. Several trials demonstrate that selected patients benefit from surgery if R0 resection is achieved. We aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38bba28156985c9bb87273aca87fca2c
https://www.zora.uzh.ch/id/eprint/228742/
https://www.zora.uzh.ch/id/eprint/228742/
Autor:
Chantal Arditi, Manuela Eicher, Sara Colomer‐Lahiguera, Christine Bienvenu, Sandro Anchisi, Daniel Betticher, Pierre‐Yves Dietrich, Michel Duchosal, Solange Peters, Isabelle Peytremann‐Bridevaux
Publikováno v:
European journal of cancer care, vol. 31, no. 6, pp. e13705
The objectives were to describe patients' experiences of cancer care in Switzerland and explore the variation of these experiences by type of cancer. The Swiss Cancer Patient Experiences (SCAPE) study was a cross-sectional, multicentre survey conduct
Autor:
Kevin Nasrinfar, Marco Mancinetti, Christian Chuard, Daniel Betticher, Andreas Samuel Ebneter
Publikováno v:
Forum Médical Suisse ‒ Swiss Medical Forum.